# Clinical Study of Clevidipine Butyrate Injection in the Treatment of Hypertensive Emergency and Sub-emergency

> **NCT05044364** · PHASE3 · UNKNOWN · sponsor: **Shenzhen People's Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Hypertensive Emergency

## Interventions

- **DRUG:** This is a randomized, single-blind, parallel-controlled clinical study with the original research clevidipine butyrate injection as the positive control drug, which is an equivalence test.

## Key facts

- **NCT ID:** NCT05044364
- **Lead sponsor:** Shenzhen People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-11
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-10-10
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05044364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05044364, "Clinical Study of Clevidipine Butyrate Injection in the Treatment of Hypertensive Emergency and Sub-emergency". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05044364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*